高级检索
    梁远红, 梁华生. 心脏再同步化治疗可降低伴有左束支传导阻滞的轻度心力衰竭患者全因死亡及心力衰竭事件风险[J]. 循证医学, 2017, 17(6): 331-334. DOI: 10.12019/j.issn.1671-5144.2017.06.005
    引用本文: 梁远红, 梁华生. 心脏再同步化治疗可降低伴有左束支传导阻滞的轻度心力衰竭患者全因死亡及心力衰竭事件风险[J]. 循证医学, 2017, 17(6): 331-334. DOI: 10.12019/j.issn.1671-5144.2017.06.005
    shu
    LIANG Yuan-hong, LIANG Hua-sheng. Cardiac Resynchronization Therapy Reduces All-Cause Death and Heart Failure Events for Mild Heart Failure with Left Bundle Branch Block[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 331-334. DOI: 10.12019/j.issn.1671-5144.2017.06.005
    Citation: LIANG Yuan-hong, LIANG Hua-sheng. Cardiac Resynchronization Therapy Reduces All-Cause Death and Heart Failure Events for Mild Heart Failure with Left Bundle Branch Block[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 331-334. DOI: 10.12019/j.issn.1671-5144.2017.06.005
    shu

    心脏再同步化治疗可降低伴有左束支传导阻滞的轻度心力衰竭患者全因死亡及心力衰竭事件风险

    Cardiac Resynchronization Therapy Reduces All-Cause Death and Heart Failure Events for Mild Heart Failure with Left Bundle Branch Block

      摘要
      • HTML全文
      • 参考文献(15)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回